Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
Difference in eGFR Values Based on Cystatin C vs Creatinine Could Indicate Higher HF Risk
July 18th 2022A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk of incident heart failure (HF).
Read More
Using AI to Screen for Preventable Infant Blindness in Underresourced Countries
July 18th 2022A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.
Read More
Research Explores Patterns of Triple Therapy Use in Patients With Inadequately Controlled COPD
July 6th 2022A cross-sectional, observational study found that triple therapy was initiated in patients with chronic obstructive pulmonary disease (COPD) who experienced poor disease control on maintenance therapy.
Read More
Mental Health, Immunizations, Sleep Focus of Barriers in Prevention and High-Value Care
June 28th 2022A panel held at the National Alliance of Healthcare Purchaser Coalitions Leadership Summits focused on mental health, immunizations, and sleep when speaking about the barriers to prevention and high-value care in these areas of medical coverage.
Read More
Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD
June 28th 2022A noninterventional study found that chart-based assessments of visual function had adequate repeatability but were limited in discriminating between no age-related macular degeneration (AMD) and intermediate AMD.
Read More
Patients With COPD Prefer Improvement of Daily Symptoms Rather Than Exacerbations
June 27th 2022A discrete choice experiment found that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) valued improvement in their daily symptoms more than improvement of exacerbations.
Read More
Influenza and PPSV23 Vaccines Evaluated for Their Ability to Stem COPD Exacerbations
June 25th 2022A cohort study found that influenza and 23-valent pneumococcal polysaccharide vaccines (PPSV23) can reduce the risk of chronic obstructive pulmonary disease (COPD)- and pneumonia-related hospitalizations.
Read More
Analysis Finds Ranibizumab PDS Cost-Saving in Long-term Scenarios
June 22nd 2022A recent study found that the ranibizumab port delivery system (PDS) has cost-saving potential compared with regular ranibizumab or aflibercept injections for age-related macular degeneration if used in the long term.
Read More
Intervention Can Help Decrease Exacerbation Rates, Improve Medication Adherence in COPD
June 15th 2022A recent study found that the Service Apothecary Respiratory Advice eHealth intervention could help patients with chronic obstructive pulmonary disease with exacerbation rates and medication adherence.
Read More
2 Commerce Drive
Cranbury, NJ 08512